UBS lowered the firm’s price target on Intuitive Surgical (ISRG) to $570 from $600 and keeps a Neutral rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- IHI, IHE, ARKG: Specialty Healthcare ETFs Can Help Boost a Portfolio
- MSFT Stock in the Spotlight as Microsoft Builds Its Own AI Model and Targets Healthcare
- Netflix, Cisco, ISRG, Visa, P&G Trending With Analysts
- Intuitive Surgical initiated with a Buy at TD Cowen
- Intuitive Surgical: Da Vinci 5 Rollout and Secular Procedure Growth Underpin TD Cowen Buy Rating and $660 Target